flanders.bio provides you with insights in the vibrant life sciences sector

 

News from flanders.bio and its members

PMV is stepping into a strategic partnership with flanders.bio as of June 1st, 2019

PMV is stepping into a strategic partnership with flanders.bio as of June 1st, 2019.
Through this partnership with flanders.bio, PMV underlines its engagement of enabling Life Science Innovation in particular in Flanders.

Read more
17
Jun
2019

PMV is stepping into a strategic partnership with flanders.bio as of June 1st, 2019

PMV is stepping into a strategic partnership with flanders.bio as of June 1st, 2019.
Through this partnership with flanders.bio, PMV underlines its engagement of enabling Life Science Innovation in particular in Flanders.

13
Jun
2019

Bone Therapeutics’ allogeneic cell therapy product, ALLOB, meets primary endpoints in Phase IIa

BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological therapeutics to address high unmet medical needs in orthopaedics and bone diseases, today announces that its allogeneic cell therapy product, ALLOB, successfully completed the 12 months follow-up period of a Phase IIa study in patients undergoing a lumbar spinal fusion procedure.

11
Jun
2019

Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients

Servier and Galapagos NV (Euronext & NASDAQ: GLPG) completed recruitment for their ROCCELLA Phase 2 trial with GLPG1972/S201086, ahead of schedule.

11
Jun
2019

VIB scientist Wout Boerjan elected as EMBO Member

EMBO is an organization of more than 1,800 leading researchers that promotes excellence in the life sciences. Each year, the organization elects new Members form a large pool of European top-scientists. EMBO membership is one of most highly prized recognitions of excellence in the life sciences for individual researchers. A deserved recognition for Prof. Wout Boerjan (VIB-UGent Center for Plant Systems Biology).

10
Jun
2019

MDxHealth (R): Multi-center Study Validates SelectMDx's High Negative Predictive Value and Sensitivity

IRVINE, CA, and HERSTAL, BELGIUM - Jun 10, 2019 - MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today announced that a second clinical validation study demonstrating the performance of its liquid biopsy test SelectMDx for Prostate Cancer has been published in the The Journal of Urology.

17
Jun
2019

PMV is stepping into a strategic partnership with flanders.bio as of June 1st, 2019

PMV is stepping into a strategic partnership with flanders.bio as of June 1st, 2019.
Through this partnership with flanders.bio, PMV underlines its engagement of enabling Life Science Innovation in particular in Flanders.

13
Jun
2019

Bone Therapeutics’ allogeneic cell therapy product, ALLOB, meets primary endpoints in Phase IIa

BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological therapeutics to address high unmet medical needs in orthopaedics and bone diseases, today announces that its allogeneic cell therapy product, ALLOB, successfully completed the 12 months follow-up period of a Phase IIa study in patients undergoing a lumbar spinal fusion procedure.

11
Jun
2019

Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients

Servier and Galapagos NV (Euronext & NASDAQ: GLPG) completed recruitment for their ROCCELLA Phase 2 trial with GLPG1972/S201086, ahead of schedule.

11
Jun
2019

VIB scientist Wout Boerjan elected as EMBO Member

EMBO is an organization of more than 1,800 leading researchers that promotes excellence in the life sciences. Each year, the organization elects new Members form a large pool of European top-scientists. EMBO membership is one of most highly prized recognitions of excellence in the life sciences for individual researchers. A deserved recognition for Prof. Wout Boerjan (VIB-UGent Center for Plant Systems Biology).

10
Jun
2019

MDxHealth (R): Multi-center Study Validates SelectMDx's High Negative Predictive Value and Sensitivity

IRVINE, CA, and HERSTAL, BELGIUM - Jun 10, 2019 - MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today announced that a second clinical validation study demonstrating the performance of its liquid biopsy test SelectMDx for Prostate Cancer has been published in the The Journal of Urology.

Facts & Figures

CONSULT OUR LIFE SCIENCE DATABASE

 

Innovation is at the core of the life sciences sector and Belgium has a track record of developing ingenious ways to improve the quality of life of millions of people worldwide.

 

Not only extensive life sciences facilities support this high-level technology industry but also financial benefits for R&D companies, international collaborations that guarantee regular cash flow, world known educational systems, a promising product pipeline, and Belgium’s unique central location in Europe.

 

Belgium concentrates on a small territory (30,528 km2) more than 300 life sciences companies with biotech activities. In total, the life sciences sector employs more than 30,000 people (low bound estimation that does not take into account indirect employment generated by the sector). The majority of the companies is related to healthcare, but Belgium also has a strong representation of agricultural and industrial biotech companies.

 

The growing life sciences sector gathers 8 main Belgian universities, 19 research parks and 23 incubators, research institutes, academic hospitals, and clinical research organizations. Biotech companies have access to more than 500,000 square feet of highly flexible infrastructure.

 

Additional assets of Belgium includes: a supportive regulatory and political environment, a highly qualified and productive workforce, a competitive tax environment especially for research companies, a prominent location and an excellent logistical and business infrastructure.

Z Life Sciences

A look behind the scenes of the vibrant life sciences sector in Flanders, Belgium in 11 episodes.

1

VIB

VIB is a life sciences research institute based in Flanders. With more than 1470 scientists from over 60 countries, they perform basic research into the molecular foundations of life and they translate this research into pharmaceutical, agricultural and industrial applications.

2

imec

imec performs world-leading research in nano-electronics and creates groundbreaking innovation in application domains such as healthcare, smart cities and mobility, logistics and manufacturing, and energy. The combination of their widely acclaimed leadership in microchip technology and profound software and ICT expertise is what makes imec unique.

3

Bio Base Europe Pilot Plant

Bio Base Europe Pilot Plant is an independent, state-of-the-art facility that operates from a laboratory level to a multi-ton scale. Bio Base Europe Pilot Plant provides process development, scale-up and custom manufacturing of biobased products and processes. 

 

Interested in a regular update of the Life Sciences and biotech sector in Flanders?